GB1208769A - New bisazomethines and medicines containing them - Google Patents

New bisazomethines and medicines containing them

Info

Publication number
GB1208769A
GB1208769A GB5352067A GB5352067A GB1208769A GB 1208769 A GB1208769 A GB 1208769A GB 5352067 A GB5352067 A GB 5352067A GB 5352067 A GB5352067 A GB 5352067A GB 1208769 A GB1208769 A GB 1208769A
Authority
GB
United Kingdom
Prior art keywords
reacting
prepared
formula
bisazomethines
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5352067A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esteve Pharmaceuticals SA
Original Assignee
Laboratorios del Dr Esteve SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR96454A external-priority patent/FR6435M/fr
Application filed by Laboratorios del Dr Esteve SA filed Critical Laboratorios del Dr Esteve SA
Publication of GB1208769A publication Critical patent/GB1208769A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/70Nitro radicals
    • C07D307/71Nitro radicals attached in position 5
    • C07D307/72Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2
    • C07D307/73Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2 by amino or imino, or substituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

1,208,769. Nitrofuran derivatives. LABORATORIOS DEL DR. ESTEVE S.A. 24 Nov., 1967 [24 Nov., 1966; 24 Feb., 1967], No. 53520/67. Heading C2C. [Also in Division A5] Novel compounds of Formula I in which each of R 1 , R 2 and R 3 is hydrogen, nitro, alkyl, alkoxy, aryl, aryloxy or halogen, are prepared by reacting 5-nitrofurfural with an amine of Formula II. The novel compounds are bacteriostats. Amines of Formula II are prepared by reacting an appropriate p-aminobenzaldehyde with semicarbazide hydrochloride. 1 - (5 - Nitrofurfurylidene - amino) - 3 - (morpholinomethyl) -hydantoin is prepared by reacting nitrofurantoin with morpholine and formaldehyde.
GB5352067A 1966-11-24 1967-11-24 New bisazomethines and medicines containing them Expired GB1208769A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES33415966 1966-11-24
FR96454A FR6435M (en) 1967-02-24 1967-02-24

Publications (1)

Publication Number Publication Date
GB1208769A true GB1208769A (en) 1970-10-14

Family

ID=26155715

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5352067A Expired GB1208769A (en) 1966-11-24 1967-11-24 New bisazomethines and medicines containing them

Country Status (2)

Country Link
BE (1) BE706907A (en)
GB (1) GB1208769A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1058550A1 (en) * 1998-02-04 2000-12-13 Euro-Celtique S.A. Substituted semicarbazides and the use thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1058550A1 (en) * 1998-02-04 2000-12-13 Euro-Celtique S.A. Substituted semicarbazides and the use thereof
EP1058550A4 (en) * 1998-02-04 2002-12-18 Euro Celtique Sa Substituted semicarbazides and the use thereof

Also Published As

Publication number Publication date
BE706907A (en) 1968-04-01

Similar Documents

Publication Publication Date Title
ES369802A1 (en) N-phenylsuccinimide derivatives
GB1150466A (en) Improvements in Colour Photography Processes
GB1208769A (en) New bisazomethines and medicines containing them
ES450380A1 (en) Indaneacetic acid derivatives
GB1037646A (en) Stabilised silver halide emulsions
GB878628A (en) Improvements in or relating to the production of nitrofuran derivatives
GB1137569A (en) Oxidazole compounds and processes for their manufacture and use
GB1129396A (en) Improvements in the production of gelatin-containing photographic layers
GB1514709A (en) Fungicidal thioamides
GB1381210A (en) Azomethines of 4-amino-5-h-1,2,4-triazin-5-ones process for their production and their use as herbicides
ES412101A1 (en) N,N{40 -diphenyl-N-(N{41 -alkylcarbamoyl)formamidines
GB1156172A (en) Monoazo Dyes Containing a Vinylsulphone Group
GB1314937A (en) Phenyl-urea derivatives and herbicidal
ES407133A1 (en) Dibenzoxirenazepine derivatives
GB1331738A (en) Quaternary thenyl ammonium salts
GB1257238A (en)
GB1227790A (en)
ES285855A1 (en) A procedure for the manufacture of benzodiazepinic derivatives (Machine-translation by Google Translate, not legally binding)
GB1129334A (en) Alkyl n-substituted-ªß-amino-ªß-alkoxyacrylates
GB1280288A (en) Pyrimidopyrimidines
ES313956A1 (en) Procedure for obtaining heterociclic piperidinic compounds. (Machine-translation by Google Translate, not legally binding)
GB1242112A (en) 3-pyrazolidinimine derivatives
ES392665A1 (en) Novel process for preparing i-substituted benzodiazepine derivatives
GB1028809A (en) Process for stabilizing photographic emulsions
GB1134889A (en) Treatment of textile materials to inhibit discolouration

Legal Events

Date Code Title Description
CSNS Application of which complete specification have been accepted and published, but patent is not sealed